Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognosis Evaluation in Patients with Hepatocellular Carcinoma after Hepatectomy: Comparison of BCLC, TNM and Hangzhou Criteria Staging Systems
Chang Liu, Li-gen Duan, Wusheng Lu, et al.
PLoS ONE (2014) Vol. 9, Iss. 8, pp. e103228-e103228
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Global Consultation on Cancer Staging: promoting consistent understanding and use
James D. Brierley, Brian O’Sullivan, Hisao Asamura, et al.
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 12, pp. 763-771
Open Access | Times Cited: 67
Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients
Berend R. Beumer, Stefan Buettner, Boris Galjart, et al.
European Journal of Surgical Oncology (2021) Vol. 48, Iss. 3, pp. 492-499
Open Access | Times Cited: 35
Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area
Kostandinos Sideras, Steven Bots, Katharina Biermann, et al.
British Journal of Cancer (2015) Vol. 112, Iss. 12, pp. 1911-1920
Open Access | Times Cited: 45
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma
Omar Abdel‐Rahman, Zeinab Elsayed
Cochrane library (2016)
Open Access | Times Cited: 39
Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment
Jui‐Hu Hsiao, Cheng‐Chung Tsai, Tsung‐Jung Liang, et al.
International Journal of Surgery (2017) Vol. 45, pp. 35-41
Open Access | Times Cited: 37
Assessment of the discriminating value of the 8th AJCC stage grouping for hepatocellular carcinoma
Omar Abdel‐Rahman
HPB (2017) Vol. 20, Iss. 1, pp. 41-48
Open Access | Times Cited: 36
Validation of models in patients with hepatocellular carcinoma
Xiaopeng Yan, Xu Fu, Chuang Cai, et al.
European Journal of Gastroenterology & Hepatology (2015) Vol. 27, Iss. 10, pp. 1180-1186
Closed Access | Times Cited: 32
Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma
Li‐Ju Chen, Yun-Jau Chang, Yao-Jen Chang
The Oncologist (2020) Vol. 26, Iss. 3, pp. e445-e453
Open Access | Times Cited: 24
Gene networks and transcriptional regulators associated with liver cancer development and progression
Tatiana Meier, Max Timm, M. Montani, et al.
BMC Medical Genomics (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma
Yanlong Shi, Guo Huang, Fei Jiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with Child–Pugh I who underwent curative resection: a prognostic nomogram study
Wei Gan, Meixia Zhang, Jiaxing Wang, et al.
Cancer Management and Research (2018) Vol. Volume 10, pp. 5383-5394
Open Access | Times Cited: 21
Preoperative alpha fetoprotein, total bilirubin, fibrinogen, albumin, and lymphocytes predict postoperative survival in hepatocellular carcinoma
Jia Xu, Shu An, Ying Lü, et al.
Cancer Medicine (2023) Vol. 12, Iss. 12, pp. 13319-13328
Open Access | Times Cited: 7
Overexpression of CD147 is associated with poor prognosis, tumor cell migration and ERK signaling pathway activation in hepatocellular carcinoma
Wenjing Xiao, Shufen Zhao, Fangzhen Shen, et al.
Experimental and Therapeutic Medicine (2017) Vol. 14, Iss. 3, pp. 2637-2642
Open Access | Times Cited: 15
Expression of Yes-associated protein in liver cancer and its correlation with clinicopathological features and prognosis of liver cancer patients.
Yi‐Ping Wang, Dongxin Tang
PubMed (2015) Vol. 8, Iss. 1, pp. 1080-6
Closed Access | Times Cited: 15
Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma
Zhen Qu, Chunhui Yuan, Changqing Yin, et al.
OncoTargets and Therapy (2016) Vol. Volume 9, pp. 5143-5152
Open Access | Times Cited: 13
Identification of a seven-gene signature predicting clinical outcome of liver cancer based on tumor mutational burden
Yunlong Cui, Ning Jiang
Human Cell (2022) Vol. 35, Iss. 4, pp. 1192-1206
Closed Access | Times Cited: 8
Integrated analysis of intratumoral biomarker and tumor-associated macrophage to improve the prognosis prediction in cancer patients
Ming-Da Wang, Hao Xiang, Tianyu Hong, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
The preoperative globulin‐to‐albumin ratio, a novel inflammation‐based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinoma
Takayuki Shimizu, Mitsuru Ishizuka, Takashi Suzuki, et al.
Journal of Surgical Oncology (2017) Vol. 116, Iss. 8, pp. 1166-1175
Closed Access | Times Cited: 12
Stage Classification and Prognosis Assessment in Localized Pancreatic Cancer: It Takes Two to Tango
Michèle Milella
Journal of Clinical Oncology (2024) Vol. 42, Iss. 12, pp. 1331-1334
Closed Access | Times Cited: 1
Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4
Shukui Qin, Xinji Zhang, Wei Guo, et al.
PubMed (2017) Vol. 18, Iss. 5, pp. 1225-1232
Closed Access | Times Cited: 10
The prognosis of bulky hepatocellular carcinoma with nonmajor branch portal vein tumor thrombosis
Tyng‐Yuan Jang, Ching‐I Huang, Ming‐Lun Yeh, et al.
Medicine (2019) Vol. 98, Iss. 13, pp. e15066-e15066
Open Access | Times Cited: 8
Seven Hub Genes Predict the Prognosis of Hepatocellular Carcinoma and the Corresponding Competitive Endogenous RNA Network
Xueqiong Han, Jianxun Lu, Chun Chen, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 5
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma
Omar Abdel‐Rahman, Zeinab El-Sayed
Cochrane library (2020)
Open Access | Times Cited: 6
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma
Omar Abdel‐Rahman, Zeinab Elsayed
Cochrane database of systematic reviews (2014)
Open Access | Times Cited: 3
Evaluation of Total Hepatocellular Cancer Lifespan, Including Both Clinically Evident and Preclinical Development, Using Combined Network Phenotyping Strategy and Fisher Information Analysis
Petr Pančoška, L. Skála, Jaroslav Nešetřil, et al.
Seminars in Oncology (2015) Vol. 42, Iss. 2, pp. 339-346
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top